Facing glycosphingolipid–Shiga toxin interaction: dire straits for endothelial cells of the human vasculature

[1]  Craig S. Wong,et al.  Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Friedrich,et al.  Promiscuous Shiga toxin 2e and its intimate relationship to Forssman. , 2012, Glycobiology.

[3]  A. Friedrich,et al.  Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells , 2012, Biological chemistry.

[4]  J. Gariépy,et al.  Charged and Hydrophobic Surfaces on the A Chain of Shiga-Like Toxin 1 Recognize the C-Terminal Domain of Ribosomal Stalk Proteins , 2012, PloS one.

[5]  P. Kubes,et al.  Innate immunity in the vasculature: interactions with pathogenic bacteria. , 2012, Current opinion in microbiology.

[6]  A. Linstedt,et al.  Manganese Blocks Intracellular Trafficking of Shiga Toxin and Protects Against Shiga Toxicosis , 2012, Science.

[7]  V. L. Tesh,et al.  Activation of cell stress response pathways by Shiga toxins , 2012, Cellular microbiology.

[8]  A. Torres,et al.  Molecular Mechanisms That Mediate Colonization of Shiga Toxin-Producing Escherichia coli Strains , 2011, Infection and Immunity.

[9]  I. Rodrı́guez-Crespo,et al.  Protein palmitoylation and subcellular trafficking. , 2011, Biochimica et biophysica acta.

[10]  J. Barbieri,et al.  Unique ganglioside binding by botulinum neurotoxins C and D‐SA , 2011, The FEBS journal.

[11]  Klaus Stark,et al.  Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. , 2011, The New England journal of medicine.

[12]  H. Karch,et al.  Recent outbreak of hemolytic uremic syndrome in Germany. , 2011, Kidney international.

[13]  R. Würzner,et al.  Inhibition of terminal complement activation in severe Shiga toxin-associated HUS – perfect example for a fast track from bench to bedside , 2011, EMBO molecular medicine.

[14]  M. Mormann,et al.  Thin-layer chromatography, overlay technique and mass spectrometry: a versatile triad advancing glycosphingolipidomics. , 2011, Biochimica et biophysica acta.

[15]  Kai Simons,et al.  Membrane organization and lipid rafts. , 2011, Cold Spring Harbor perspectives in biology.

[16]  Y. Maeda,et al.  Structural remodeling, trafficking and functions of glycosylphosphatidylinositol-anchored proteins. , 2011, Progress in lipid research.

[17]  Alfred H. Merrill,et al.  Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics , 2011, Chemical reviews.

[18]  S. Felix,et al.  Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial , 2011, The Lancet.

[19]  Jing Huang,et al.  Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways. , 2011, Blood.

[20]  A. Mellmann,et al.  Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. , 2011, The Lancet. Infectious diseases.

[21]  G. Węgrzyn,et al.  Bacteriophages carrying Shiga toxin genes: genomic variations, detection and potential treatment of pathogenic bacteria. , 2011, Future microbiology.

[22]  M. Fessler,et al.  Intracellular Lipid Flux and Membrane Microdomains as Organizing Principles in Inflammatory Cell Signaling , 2011, The Journal of Immunology.

[23]  A. Mellmann,et al.  Comparison of Multilocus Variable-Number Tandem-Repeat Analysis and Multilocus Sequence Typing for Differentiation of Hemolytic-Uremic Syndrome-Associated Escherichia coli (HUSEC) Collection Strains , 2011, Journal of Clinical Microbiology.

[24]  M. Amelia,et al.  Change in Conformation with Reduction of α-Helix Content Causes Loss of Neutrophil Binding Activity in Fully Cytotoxic Shiga Toxin 1* , 2011, The Journal of Biological Chemistry.

[25]  Ari Helenius,et al.  Lipid-mediated endocytosis. , 2011, Cold Spring Harbor perspectives in biology.

[26]  R. Langer,et al.  Tumor-Specific Targeting of Pancreatic Cancer with Shiga Toxin B-Subunit , 2011, Molecular Cancer Therapeutics.

[27]  J. Rothberg,et al.  Prospective Genomic Characterization of the German Enterohemorrhagic Escherichia coli O104:H4 Outbreak by Rapid Next Generation Sequencing Technology , 2011, PloS one.

[28]  S. Bloom,et al.  Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. , 2011, Microbiology.

[29]  D. Leyva-Illades,et al.  Differential Response of the Human Renal Proximal Tubular Epithelial Cell Line HK-2 to Shiga Toxin Types 1 and 2 , 2011, Infection and Immunity.

[30]  Jian Zhong,et al.  From simple to complex: investigating the effects of lipid composition and phase on the membrane interactions of biomolecules using in situ atomic force microscopy. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[31]  G. Koudelka,et al.  Shiga Toxin: Expression, Distribution, and Its Role in the Environment , 2011, Toxins.

[32]  A. Edefonti,et al.  Clinical Relevance of Shiga Toxin Concentrations in the Blood of Patients With Hemolytic Uremic Syndrome , 2011, The Pediatric infectious disease journal.

[33]  S. Schüller.  Shiga Toxin Interaction with Human Intestinal Epithelium , 2011, Toxins.

[34]  G Krause,et al.  Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[35]  D. Lingwood,et al.  Cholesterol modulates glycolipid conformation and receptor activity. , 2011, Nature chemical biology.

[36]  H. Karch,et al.  Enterohaemorrhagic Escherichia coli haemolysin is cleaved and inactivated by serine protease EspPα , 2011, Environmental microbiology.

[37]  A. Friedrich,et al.  Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains[S] , 2011, Journal of Lipid Research.

[38]  C. Hovde,et al.  Escherichia coli O157:H7: animal reservoir and sources of human infection. , 2011, Foodborne pathogens and disease.

[39]  M. Miyazaki,et al.  Fatal hemorrhage induced by subtilase cytotoxin from Shiga-toxigenic Escherichia coli. , 2011, Microbial pathogenesis.

[40]  N. Engedal,et al.  Toll-like receptor 4 facilitates binding of Shiga toxin to colon carcinoma and primary umbilical vein endothelial cells. , 2011, FEMS immunology and medical microbiology.

[41]  N. Engedal,et al.  Shiga toxin and its use in targeted cancer therapy and imaging , 2010, Microbial biotechnology.

[42]  K. Sandvig,et al.  Endocytosis and retrograde transport of Shiga toxin. , 2010, Toxicon : official journal of the International Society on Toxinology.

[43]  Patrik Langehanenberg,et al.  Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells , 2010, Thrombosis and Haemostasis.

[44]  T. Obrig.  Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease , 2010, Toxins.

[45]  A. Callan-Jones,et al.  Lipid Cosorting Mediated by Shiga Toxin Induced Tubulation , 2010, Traffic.

[46]  P. Tazzari,et al.  Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor. , 2010, The Biochemical journal.

[47]  D. Motto,et al.  Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice. , 2010, Blood.

[48]  J. Paton,et al.  Tissue factor–dependent procoagulant activity of subtilase cytotoxin, a potent AB5 toxin produced by shiga toxigenic Escherichia coli. , 2010, The Journal of infectious diseases.

[49]  M. Schmidt,et al.  LEEways: tales of EPEC, ATEC and EHEC , 2010, Cellular microbiology.

[50]  Kai Simons,et al.  Revitalizing membrane rafts: new tools and insights , 2010, Nature Reviews Molecular Cell Biology.

[51]  H. Buhr,et al.  Specific targeting of tumor endothelial cells by a shiga-like toxin-vascular endothelial growth factor fusion protein as a novel treatment strategy for pancreatic cancer. , 2010, Neoplasia.

[52]  P. Quinn.  A lipid matrix model of membrane raft structure. , 2010, Progress in lipid research.

[53]  E. Kita,et al.  Enhanced expression of ATP-binding cassette transporter A1 in non-rafts decreases the sensitivity of vascular endothelial cells to Shiga toxin. , 2010, Microbial pathogenesis.

[54]  Dora Brites,et al.  Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches , 2010, Brain Research Reviews.

[55]  S. Johnson,et al.  Pathophysiology of typical hemolytic uremic syndrome. , 2010, Seminars in thrombosis and hemostasis.

[56]  A. Mellmann,et al.  Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation. , 2010, Seminars in thrombosis and hemostasis.

[57]  F. Schaefer,et al.  Treatment of typical (enteropathic) hemolytic uremic syndrome. , 2010, Seminars in thrombosis and hemostasis.

[58]  R. Inagi,et al.  Glomerular diseases: genetic causes and future therapeutics , 2010, Nature Reviews Nephrology.

[59]  R. Würzner,et al.  Complement in typical hemolytic uremic syndrome. , 2010, Seminars in thrombosis and hemostasis.

[60]  C. Ackerley,et al.  A Major Fraction of Glycosphingolipids in Model and Cellular Cholesterol-containing Membranes Is Undetectable by Their Binding Proteins* , 2010, The Journal of Biological Chemistry.

[61]  A. Friedrich,et al.  On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.

[62]  A. Friedrich,et al.  Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors[S] , 2010, Journal of Lipid Research.

[63]  A. Caprioli,et al.  Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration , 2010, Journal of leukocyte biology.

[64]  R. Coutinho-Silva,et al.  Host‐cell lipid rafts: a safe door for micro‐organisms? , 2010, Biology of the cell.

[65]  T. Beddoe,et al.  Structure, biological functions and applications of the AB5 toxins. , 2010, Trends in biochemical sciences.

[66]  Tore-Geir Iversen,et al.  Protein toxins from plants and bacteria: Probes for intracellular transport and tools in medicine , 2010, FEBS letters.

[67]  Jaakko Patrakka,et al.  Molecular make-up of the glomerular filtration barrier. , 2010, Biochemical and biophysical research communications.

[68]  R. Yu,et al.  Membrane glycolipids in stem cells , 2010, FEBS letters.

[69]  B. Binnington,et al.  Globotriaosyl ceramide receptor function – Where membrane structure and pathology intersect , 2010, FEBS letters.

[70]  R. Kolesnick,et al.  Ceramide‐rich platforms in transmembrane signaling , 2010, FEBS letters.

[71]  A. Surolia,et al.  Glycosphingolipids in microdomain formation and their spatial organization , 2010, FEBS letters.

[72]  K. Iwabuchi,et al.  Significance of glycosphingolipid fatty acid chain length on membrane microdomain‐mediated signal transduction , 2010, FEBS letters.

[73]  S. Hakomori.  Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility , 2010, FEBS letters.

[74]  Patrik Langehanenberg,et al.  Label-free quantitative cell division monitoring of endothelial cells by digital holographic microscopy. , 2010, Journal of biomedical optics.

[75]  J. Müthing,et al.  Advances on the compositional analysis of glycosphingolipids combining thin-layer chromatography with mass spectrometry. , 2010, Mass spectrometry reviews.

[76]  W. Sessa,et al.  Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. , 2010, Cardiovascular research.

[77]  C. Schengrund.  Lipid rafts: Keys to neurodegeneration , 2010, Brain Research Bulletin.

[78]  M. Morigi,et al.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction , 2010, Pediatric Nephrology.

[79]  C. G. Hansen,et al.  Exploring the caves: cavins, caveolins and caveolae. , 2010, Trends in cell biology.

[80]  S. Tzipori,et al.  Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2. , 2010, The Journal of infectious diseases.

[81]  V. L. Tesh.  Induction of apoptosis by Shiga toxins. , 2010, Future microbiology.

[82]  S. Iyer,et al.  Glycan‐based high‐affinity ligands for toxins and pathogen receptors , 2010, Medicinal research reviews.

[83]  J. Hunt.  Shiga Toxin–Producing Escherichia coli (STEC) , 2010, Clinics in Laboratory Medicine.

[84]  L. Johannes,et al.  Shiga toxins — from cell biology to biomedical applications , 2010, Nature Reviews Microbiology.

[85]  M. Veit,et al.  FLIM-FRET and FRAP reveal association of influenza virus haemagglutinin with membrane rafts. , 2010, The Biochemical journal.

[86]  S. Bourdoulous,et al.  Breaking the wall: targeting of the endothelium by pathogenic bacteria , 2010, Nature Reviews Microbiology.

[87]  J. Paton,et al.  Escherichia coli Subtilase Cytotoxin , 2010, Toxins.

[88]  V. Gannon,et al.  Verocytotoxin-producing Escherichia coli (VTEC). , 2010, Veterinary microbiology.

[89]  K. Sandvig,et al.  Interplay between Toxin Transport and Flotillin Localization , 2010, PloS one.

[90]  T. Okuda,et al.  Structural characterization and dynamics of globotetraosylceramide in vascular endothelial cells under TNF-α stimulation , 2010, Glycoconjugate Journal.

[91]  Kai Simons,et al.  Lipid Rafts As a Membrane-Organizing Principle , 2010, Science.

[92]  Richard J Thomas,et al.  Receptor mimicry as novel therapeutic treatment for biothreat agents , 2010, Bioengineered bugs.

[93]  T. Johnson,et al.  Pathogenomics of the Virulence Plasmids of Escherichia coli , 2009, Microbiology and Molecular Biology Reviews.

[94]  H. Schnittler,et al.  Between microbial attack and defence: The endothelium as a vulnerable player in infectious diseases , 2009, Thrombosis and Haemostasis.

[95]  Shefali Sabharanjak,et al.  Endocytosis of glycosylphosphatidylinositol-anchored proteins , 2009, Journal of Biomedical Science.

[96]  John Cowden,et al.  Escherichia coli O157 , 2009, BMJ : British Medical Journal.

[97]  A. Brunger,et al.  Receptor and substrate interactions of clostridial neurotoxins. , 2009, Toxicon : official journal of the International Society on Toxinology.

[98]  R. Schnaar,et al.  Gangliosides in cell recognition and membrane protein regulation. , 2009, Current opinion in structural biology.

[99]  C. Lingwood,et al.  Fatty acid-dependent globotriaosyl ceramide receptor function in detergent resistant model membranes , 2009, Journal of Lipid Research.

[100]  A. Friedrich,et al.  Shiga Toxin Receptor Gb3Cer/CD77: Tumor-Association and Promising Therapeutic Target in Pancreas and Colon Cancer , 2009, PloS one.

[101]  K. Iwabuchi,et al.  Role of very long fatty acid-containing glycosphingolipids in membrane organization and cell signaling: the model of lactosylceramide in neutrophils , 2009, Glycoconjugate Journal.

[102]  A. Varki,et al.  A dietary non-human sialic acid may facilitate hemolytic-uremic syndrome. , 2009, Kidney international.

[103]  M. Mehran,et al.  Safety and Pharmacokinetics of Chimeric Anti-Shiga Toxin 1 and Anti-Shiga Toxin 2 Monoclonal Antibodies in Healthy Volunteers , 2009, Antimicrobial Agents and Chemotherapy.

[104]  A. Shevchenko,et al.  Glycosphingolipid Requirements for Endosome‐to‐Golgi Transport of Shiga Toxin , 2009, Traffic.

[105]  C. G. Hansen,et al.  Molecular mechanisms of clathrin-independent endocytosis , 2009, Journal of Cell Science.

[106]  T. Binz,et al.  Cell entry strategy of clostridial neurotoxins , 2009, Journal of neurochemistry.

[107]  C. Lingwood,et al.  Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. , 2009, Kidney international.

[108]  H. Karch,et al.  Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome1 , 2009, The Journal of Immunology.

[109]  A. Mellmann,et al.  Intrahost genome alterations in enterohemorrhagic Escherichia coli. , 2009, Gastroenterology.

[110]  A. Mellmann,et al.  Shiga Toxin, Cytolethal Distending Toxin, and Hemolysin Repertoires in Clinical Escherichia coli O91 Isolates , 2009, Journal of Clinical Microbiology.

[111]  H. Karch,et al.  Vesicular stabilization and activity augmentation of enterohaemorrhagic Escherichia coli haemolysin , 2009, Molecular microbiology.

[112]  S. Hell,et al.  Direct observation of the nanoscale dynamics of membrane lipids in a living cell , 2009, Nature.

[113]  S. Sonnino,et al.  Sphingolipids and membrane environments for caveolin , 2009, FEBS letters.

[114]  W. Min,et al.  Mechanisms of endothelial dysfunction, injury, and death. , 2009, Annual review of pathology.

[115]  M. Bitzan.  Treatment options for HUS secondary to Escherichia coli O157:H7. , 2009, Kidney international. Supplement.

[116]  A. Friedrich,et al.  Shiga toxins, glycosphingolipid diversity, and endothelial cell injury , 2009, Thrombosis and Haemostasis.

[117]  F. Braet,et al.  Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier , 2009, American journal of physiology. Renal physiology.

[118]  David F. Smith,et al.  Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin , 2008, Nature.

[119]  A. Bonev,et al.  Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. , 2008, The Journal of infectious diseases.

[120]  A. Caprioli,et al.  Interactions between Shiga toxins and human polymorphonuclear leukocytes , 2008, Journal of leukocyte biology.

[121]  L. P. Van den Heuvel,et al.  Shiga-toxin-induced firm adhesion of human leukocytes to endothelium is in part mediated by heparan sulfate. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[122]  B. Binnington,et al.  Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide‐containing lipid assemblies , 2008, Journal of cellular physiology.

[123]  L. Zimmerhackl,et al.  Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS) , 2008, Pediatric Nephrology.

[124]  A. Mellmann,et al.  Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli , 2008, Emerging infectious diseases.

[125]  P. Sens,et al.  Biophysical approaches to protein-induced membrane deformations in trafficking. , 2008, Current opinion in cell biology.

[126]  M. Noda,et al.  Effect of Gb3 in lipid rafts in resistance to Shiga-like toxin of mutant Vero cells. , 2008, Microbial pathogenesis.

[127]  X. Sastre,et al.  Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool , 2008, Molecular Cancer Therapeutics.

[128]  G. Remuzzi,et al.  Fractalkine and CX3CR1 Mediate Leukocyte Capture by Endothelium in Response to Shiga Toxin1 , 2008, The Journal of Immunology.

[129]  C. Silberstein,et al.  Inhibition of water absorption in human proximal tubular epithelial cells in response to Shiga toxin-2 , 2008, Pediatric Nephrology.

[130]  T. Yutsudo,et al.  Shiga Toxin 2 Causes Apoptosis in Human Brain Microvascular Endothelial Cells via C/EBP Homologous Protein , 2008, Infection and Immunity.

[131]  K. Iwabuchi,et al.  Role of glycosphingolipid-enriched microdomains in innate immunity: microdomain-dependent phagocytic cell functions. , 2008, Biochimica et biophysica acta.

[132]  R. Cherla,et al.  Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells , 2008, Cellular microbiology.

[133]  S. Hakomori,et al.  Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. , 2008, Biochimica et biophysica acta.

[134]  S. Hakomori.  Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. , 2008, Biochimica et biophysica acta.

[135]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[136]  B. Kemper,et al.  Digital holographic microscopy for live cell applications and technical inspection. , 2008, Applied optics.

[137]  K. Sandvig,et al.  Clathrin-independent endocytosis: from nonexisting to an extreme degree of complexity , 2008, Histochemistry and Cell Biology.

[138]  A. Friedrich,et al.  Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity , 2008, Glycoconjugate Journal.

[139]  E. Boedeker,et al.  Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections , 2008, Current opinion in gastroenterology.

[140]  T. Obrig,et al.  p38 Mitogen-Activated Protein Kinase Mediates Lipopolysaccharide and Tumor Necrosis Factor Alpha Induction of Shiga Toxin 2 Sensitivity in Human Umbilical Vein Endothelial Cells , 2007, Infection and Immunity.

[141]  Katharina Gaus,et al.  Shiga toxin induces tubular membrane invaginations for its uptake into cells , 2007, Nature.

[142]  P. Marquet,et al.  Digital holographic microscopy applied to life sciences , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[143]  D. Lingwood,et al.  Detergent resistance as a tool in membrane research , 2007, Nature Protocols.

[144]  D. Vestweber.  Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium , 2007, Immunological reviews.

[145]  N. Suttorp,et al.  Extra- and intracellular innate immune recognition in endothelial cells , 2007, Thrombosis and Haemostasis.

[146]  A. Mellmann,et al.  Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[147]  A. Futerman,et al.  The metabolism and function of sphingolipids and glycosphingolipids , 2007, Cellular and Molecular Life Sciences.

[148]  B. Ballermann.  Contribution of the Endothelium to the Glomerular Permselectivity Barrier in Health and Disease , 2007, Nephron Physiology.

[149]  L. P. Van den Heuvel,et al.  Interactions of Shiga-like toxin with human peripheral blood monocytes , 2007, Pediatric Nephrology.

[150]  J. Hancock,et al.  Lipid rafts and membrane traffic , 2007, FEBS letters.

[151]  Ajit Varki,et al.  Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins , 2007, Nature.

[152]  B. Tesfamariam,et al.  Endothelial injury in the initiation and progression of vascular disorders. , 2007, Vascular pharmacology.

[153]  M. Bakovic,et al.  Lipid rafts in health and disease , 2007, Biology of the cell.

[154]  R. Parton,et al.  The multiple faces of caveolae , 2007, Nature Reviews Molecular Cell Biology.

[155]  A. Friedrich,et al.  Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium. , 2007, Microbes and infection.

[156]  R. Titball,et al.  The Rational Design of Bacterial Toxin Inhibitors , 2007 .

[157]  Mark M. Rasenick,et al.  Lipid raft microdomains and neurotransmitter signalling , 2007, Nature Reviews Neuroscience.

[158]  N. Wilke,et al.  Biophysics of sphingolipids II. Glycosphingolipids: an assortment of multiple structural information transducers at the membrane surface. , 2006, Biochimica et biophysica acta.

[159]  J. van Marle,et al.  Spatial segregation of transport and signalling functions between human endothelial caveolae and lipid raft proteomes. , 2006, The Biochemical journal.

[160]  L. Johannes,et al.  Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells. , 2006, Kidney international.

[161]  J. Paton,et al.  Shiga toxin 'goes retro' in human primary kidney cells. , 2006, Kidney international.

[162]  Deborah A. Brown,et al.  Lipid rafts, detergent-resistant membranes, and raft targeting signals. , 2006, Physiology.

[163]  L. Johannes,et al.  Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells , 2006, The FEBS journal.

[164]  L. Monnens,et al.  Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells , 2006, Pediatric Nephrology.

[165]  R. Henriksson,et al.  Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines , 2006, Cancer biology & therapy.

[166]  Y. Fujinaga.  Transport of bacterial toxins into target cells: pathways followed by cholera toxin and botulinum progenitor toxin. , 2006, Journal of biochemistry.

[167]  H. Tsai.  The molecular biology of thrombotic microangiopathy. , 2006, Kidney international.

[168]  M. James,et al.  Binding of adenine to Stx2, the protein toxin from Escherichia coli O157:H7. , 2006, Acta crystallographica. Section F, Structural biology and crystallization communications.

[169]  Ryuzo Azuma,et al.  Particle simulation approach for subcellular dynamics and interactions of biological molecules , 2006, First International Multi-Symposiums on Computer and Computational Sciences (IMSCCS'06).

[170]  N. Kahya.  Targeting membrane proteins to liquid-ordered phases: molecular self-organization explored by fluorescence correlation spectroscopy. , 2006, Chemistry and physics of lipids.

[171]  Sandro Sonnino,et al.  Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains. , 2006, Chemical reviews.

[172]  Wei Lang,et al.  Advancing glycomics: implementation strategies at the consortium for functional glycomics. , 2006, Glycobiology.

[173]  A. Friedrich,et al.  Cytolethal Distending Toxin in Escherichia coli O157:H7: Spectrum of Conservation, Structure, and Endothelial Toxicity , 2006, Journal of Clinical Microbiology.

[174]  L. V. D. Heuvel,et al.  Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. , 2006, Kidney international.

[175]  R. Spooner,et al.  Retrograde transport pathways utilised by viruses and protein toxins , 2006, Virology Journal.

[176]  C. Mineo,et al.  Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae. , 2006, Cardiovascular research.

[177]  Nathan Sharon,et al.  Carbohydrates as future anti-adhesion drugs for infectious diseases. , 2006, Biochimica et biophysica acta.

[178]  A. Friedrich,et al.  New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. , 2006, Seminars in thrombosis and hemostasis.

[179]  C. Silberstein,et al.  Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells. , 2006, Microbes and infection.

[180]  R. Pagano,et al.  Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids (Review) , 2006, Molecular membrane biology.

[181]  A. Friedrich,et al.  Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1. , 2005, Rapid communications in mass spectrometry : RCM.

[182]  W. Lencer,et al.  Raft trafficking of AB5 subunit bacterial toxins. , 2005, Biochimica et biophysica acta.

[183]  S. Abraham,et al.  The role of lipid rafts in the pathogenesis of bacterial infections. , 2005, Biochimica et biophysica acta.

[184]  L. Johannes,et al.  Article Title: the Association of Shiga-like Toxin with Detergent-resistant Membranes Is Modulated by Glucosylceramide and Is an Essential Requirement in the Endoplasmic Reticulum for a Cytotoxic Effect the Association of Shiga-like Toxin with Detergent- Resistant Membranes Is Modulated by Glucosylc , 2022 .

[185]  Christian G Elowsky,et al.  The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[186]  J. Moake,et al.  Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. , 2005, Blood.

[187]  R. Polanowska-Grabowska,et al.  Shiga Toxin 2 and Lipopolysaccharide Induce Human Microvascular Endothelial Cells To Release Chemokines and Factors That Stimulate Platelet Function , 2005, Infection and Immunity.

[188]  H. Karch,et al.  Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.

[189]  K. Sandvig,et al.  Caveolae: Stable Membrane Domains with a Potential for Internalization , 2005, Traffic.

[190]  F. Goñi,et al.  Detergent-resistant membranes should not be identified with membrane rafts. , 2005, Trends in biochemical sciences.

[191]  H. Karch,et al.  Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium , 2005, Thrombosis and Haemostasis.

[192]  Ken Hatano,et al.  Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation. , 2005, The Journal of infectious diseases.

[193]  J. Garvin,et al.  Recent advances in the regulation of nitric oxide in the kidney. , 2005, Hypertension.

[194]  C. Tacket,et al.  Phase 1 Safety and Pharmacokinetic Study of Chimeric Murine-Human Monoclonal Antibody cαStx2 Administered Intravenously to Healthy Adult Volunteers , 2005, Antimicrobial Agents and Chemotherapy.

[195]  J. Ingelfinger,et al.  Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome * , 2005, Journal of thrombosis and haemostasis : JTH.

[196]  Xiang-An Li,et al.  Caveolae, lipid rafts, and vascular disease. , 2005, Trends in cardiovascular medicine.

[197]  D. Haslam,et al.  Shiga Toxin Is Transported from the Endoplasmic Reticulum following Interaction with the Luminal Chaperone HEDJ/ERdj3 , 2005, Infection and Immunity.

[198]  P. Tarr,et al.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.

[199]  L. Johannes,et al.  Cholera and Shiga toxin B-subunits: thermodynamic and structural considerations for function and biomedical applications. , 2005, Toxicon : official journal of the International Society on Toxinology.

[200]  E. Cuche,et al.  Digital holographic microscopy: a noninvasive contrast imaging technique allowing quantitative visualization of living cells with subwavelength axial accuracy. , 2005, Optics letters.

[201]  L. Barbieri,et al.  Shiga toxin 1 and ricin inhibit the repair of H2O2-induced DNA single strand breaks in cultured mammalian cells. , 2005, DNA repair.

[202]  P. Stricklett,et al.  Inhibition of p38 mitogen-activated protein kinase ameliorates cytokine up-regulated shigatoxin-1 toxicity in human brain microvascular endothelial cells. , 2005, The Journal of infectious diseases.

[203]  H. Karch,et al.  Cytolethal Distending Toxin from Shiga Toxin-Producing Escherichia coli O157 Causes Irreversible G2/M Arrest, Inhibition of Proliferation, and Death of Human Endothelial Cells , 2005, Infection and Immunity.

[204]  Daniel Carl,et al.  Parameter-optimized digital holographic microscope for high-resolution living-cell analysis. , 2004, Applied optics.

[205]  A. Macconnachie,et al.  Potential therapeutic agents for the prevention and treatment of haemolytic uraemic syndrome in shiga toxin producing Escherichia coli infection , 2004, Current opinion in infectious diseases.

[206]  M. Lisanti,et al.  Role of caveolae and caveolins in health and disease. , 2004, Physiological reviews.

[207]  T. Kanda,et al.  Glycosphingolipid composition of primary cultured human brain microvascular endothelial cells , 2004, Journal of neuroscience research.

[208]  L. Johannes,et al.  Glycosphingolipids as toxin receptors. , 2004, Seminars in cell & developmental biology.

[209]  N. Kiyokawa,et al.  Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells , 2004, Journal of Cell Science.

[210]  J. Peter-Katalinic,et al.  Direct analysis of silica gel extracts from immunostained glycosphingolipids by nanoelectrospray ionization quadrupole time-of-flight mass spectrometry. , 2004, Analytical chemistry.

[211]  D. Newburg,et al.  Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells. , 2004, Microbial pathogenesis.

[212]  M. Brigotti,et al.  Shiga toxin 1 acting on DNA in vitro is a heat-stable enzyme not requiring proteolytic activation. , 2004, Biochimie.

[213]  E. Kita,et al.  Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections. , 2004, The Journal of infectious diseases.

[214]  M. Karmali.  Prospects for preventing serious systemic toxemic complications of Shiga toxin-producing Escherichia coli infections using Shiga toxin receptor analogues. , 2004, The Journal of infectious diseases.

[215]  E. Gratton,et al.  Visualizing lipid structure and raft domains in living cells with two-photon microscopy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[216]  S. Munro.  Lipid Rafts Elusive or Illusive? , 2003, Cell.

[217]  J. Peter-Katalinic,et al.  Discrimination of neolacto-series gangliosides with alpha2-3- and alpha2-6-linked N-acetylneuraminic acid by nanoelectrospray ionization low-energy collision-induced dissociation tandem quadrupole TOF MS. , 2003, Analytical chemistry.

[218]  A. Cnaan,et al.  Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial. , 2003, JAMA.

[219]  David Botstein,et al.  Endothelial cell diversity revealed by global expression profiling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[220]  R. Parton,et al.  Lipid Rafts and Caveolae as Portals for Endocytosis: New Insights and Common Mechanisms , 2003, Traffic.

[221]  N. Koide,et al.  Human microvascular endothelial cells resist Shiga toxins by IFN-γ treatment in vitro , 2003 .

[222]  F. Gunzer,et al.  Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells. , 2003, Blood.

[223]  J. Harlan,et al.  Shiga toxin induces decreased expression of the anti-apoptotic protein Mcl-1 concomitant with the onset of endothelial apoptosis. , 2003, Microbial pathogenesis.

[224]  David S. Park,et al.  Caveolin, Caveolae, and Endothelial Cell Function , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[225]  J. Fantini.  How sphingolipids bind and shape proteins: molecular basis of lipid-protein interactions in lipid shells, rafts and related biomembrane domains , 2003, Cellular and Molecular Life Sciences CMLS.

[226]  K. Sandhoff,et al.  Biosynthesis and degradation of mammalian glycosphingolipids. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[227]  Ivan R. Nabi,et al.  Caveolae/raft-dependent endocytosis , 2003, The Journal of cell biology.

[228]  W. Aird.  Endothelial cell heterogeneity , 2003, Critical care medicine.

[229]  P. Marcato,et al.  Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. , 2003, The Journal of infectious diseases.

[230]  A. Pavan,et al.  Role of GM3-enriched microdomains in signal transduction regulation in T lymphocytes , 2003, Glycoconjugate Journal.

[231]  C. Lingwood,et al.  Induction by Sphingomyelinase of Shiga Toxin Receptor and Shiga Toxin 2 Sensitivity in Human Microvascular Endothelial Cells , 2003, Infection and Immunity.

[232]  K. Sandvig,et al.  Caveolae: anchored, multifunctional platforms in the lipid ocean. , 2003, Trends in cell biology.

[233]  J. Harlan,et al.  Shiga-like Toxin Inhibition of FLICE-like Inhibitory Protein Expression Sensitizes Endothelial Cells to Bacterial Lipopolysaccharide-induced Apoptosis* , 2002, The Journal of Biological Chemistry.

[234]  K. Sandvig,et al.  Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin , 2002, FEBS letters.

[235]  P. Stricklett,et al.  Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression. , 2002, The Journal of infectious diseases.

[236]  A. Kenworthy,et al.  Peering inside lipid rafts and caveolae. , 2002, Trends in biochemical sciences.

[237]  P. Stricklett,et al.  Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: upregulation of globotriaosylceramide expression. , 2002, Journal of the American Society of Nephrology : JASN.

[238]  G. Remuzzi,et al.  Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. , 2002, Kidney international.

[239]  R. Proia,et al.  Combinatorial Ganglioside Biosynthesis* , 2002, The Journal of Biological Chemistry.

[240]  Ken Jacobson,et al.  A Role for Lipid Shells in Targeting Proteins to Caveolae, Rafts, and Other Lipid Domains , 2002, Science.

[241]  R. Stan.  Structure and function of endothelial caveolae , 2002, Microscopy research and technique.

[242]  Chisato Yamasaki,et al.  A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[243]  L. Barbieri,et al.  Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells 1 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[244]  David G. E. Smith,et al.  Expression of receptors for verotoxin 1 from Escherichia coli O157 on bovine intestinal epithelium. , 2002, Journal of medical microbiology.

[245]  A. Varki.  Loss of N‐glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution , 2002, American journal of physical anthropology.

[246]  S. Hakomori.  INAUGURAL ARTICLE by a Recently Elected Academy Member:The glycosynapse , 2002 .

[247]  H Nakajima,et al.  Kinetic Analysis of Binding between Shiga Toxin and Receptor Glycolipid Gb3Cer by Surface Plasmon Resonance* , 2001, The Journal of Biological Chemistry.

[248]  M. Donowitz,et al.  Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. , 2001, Journal of cell science.

[249]  G. Remuzzi,et al.  Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. , 2001, Blood.

[250]  G J Davies,et al.  Protein--carbohydrate interactions: learning lessons from nature. , 2001, Trends in biotechnology.

[251]  G. Remuzzi,et al.  Thrombotic microangiopathy, hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: Rare manifestations of Russell’s viper (Daboia russelii) envenoming in Sri Lanka , 2021 .

[252]  J. Salamero,et al.  Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. , 2001, Molecular biology of the cell.

[253]  G. Molostvov,et al.  Interaction of cytokines and growth factor in the regulation of verotoxin‐induced apoptosis in cultured human endothelial cells , 2001, British journal of haematology.

[254]  V. V. van Hinsbergh,et al.  Verocytotoxin-induced apoptosis of human microvascular endothelial cells. , 2001, Journal of the American Society of Nephrology : JASN.

[255]  R. Morona,et al.  Neutralization of Shiga Toxins Stx1, Stx2c, and Stx2e by Recombinant Bacteria Expressing Mimics of Globotriose and Globotetraose , 2001, Infection and Immunity.

[256]  J. Pober,et al.  Tumor Necrosis Factor Alpha Increases Human Cerebral Endothelial Cell Gb3 and Sensitivity to Shiga Toxin , 2001, Infection and Immunity.

[257]  P. Accorsi,et al.  Shiga toxin 1: damage to DNA in vitro. , 2001, Toxicon : official journal of the International Society on Toxinology.

[258]  Tetsuya Mori,et al.  Apoptosis of Renal Tubular Cells in Shiga-Toxin-Mediated Hemolytic Uremic Syndrome , 2001, Nephron.

[259]  D. Brown,et al.  Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). , 2000, Biochimica et biophysica acta.

[260]  Craig S. Wong,et al.  The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. , 2000, The New England journal of medicine.

[261]  V. V. van Hinsbergh,et al.  Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. , 2000, Blood.

[262]  Y. Sanai,et al.  Functional roles of glycosphingolipids in signal transduction via lipid rafts , 2000, Glycoconjugate Journal.

[263]  J. Fantini,et al.  Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: Activation of signal transduction pathways and perturbations of intestinal absorption and secretion , 2000, Glycoconjugate Journal.

[264]  S. Hakomori.  Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain , 2000, Glycoconjugate Journal.

[265]  R. Morona,et al.  A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans , 2000, Nature Medicine.

[266]  R. Read,et al.  Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands , 2000, Nature.

[267]  L. Johannes,et al.  Facing Inward from Compartment Shores: How Many Pathways were we Looking For? , 2000, Traffic.

[268]  Tetsuya Mori,et al.  Activation of Src Family Kinase Yes Induced by Shiga Toxin Binding to Globotriaosyl Ceramide (Gb3/CD77) in Low Density, Detergent-insoluble Microdomains* , 1999, The Journal of Biological Chemistry.

[269]  N. Koide,et al.  Primary cultures of human endothelial cells are susceptible to low doses of Shiga toxins and undergo apoptosis. , 1999, The Journal of infectious diseases.

[270]  C. Lingwood.  Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology. , 1999, Biochimica et biophysica acta.

[271]  J. Samuel,et al.  Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. , 1999, The Journal of infectious diseases.

[272]  J. Peter-Katalinic,et al.  Isolation and structural characterization of glycosphingolipids of in vitro propagated human umbilical vein endothelial cells. , 1999, Glycobiology.

[273]  Y. Ihara,et al.  Localization of verotoxin receptors in nervous system , 1999, Brain Research.

[274]  D. Acheson,et al.  Responses of Human Intestinal Microvascular Endothelial Cells to Shiga Toxins 1 and 2 and Pathogenesis of Hemorrhagic Colitis , 1999, Infection and Immunity.

[275]  J. Rutka,et al.  Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells , 1998, Journal of Neuro-Oncology.

[276]  Jcbn.  Nomenclature of glycolipids , 1998 .

[277]  M.Alan Chester,et al.  IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids--recommendations 1997. , 1998, European journal of biochemistry.

[278]  N. Kiyokawa,et al.  Human microvascular endothelial cells are strongly sensitive to Shiga toxins. , 1998, Biochemical and biophysical research communications.

[279]  H. Abboud,et al.  Shiga toxin 1 elicits diverse biologic responses in mesangial cells. , 1998, Kidney international.

[280]  L. Barbieri,et al.  Shiga‐like toxin I is a polynucleotide:adenosine glycosidase , 1998, Molecular microbiology.

[281]  R J Read,et al.  Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. , 1998, Biochemistry.

[282]  V. V. van Hinsbergh,et al.  Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. , 1997, Journal of the American Society of Nephrology : JASN.

[283]  T. Obrig,et al.  Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB , 1997, Infection and immunity.

[284]  F. Gilles,et al.  Selective expression of adhesion molecules on human brain microvascular endothelial cells , 1997, Journal of Neuroimmunology.

[285]  V. V. van Hinsbergh,et al.  Effects of TNFα on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells , 1997 .

[286]  D. Acheson,et al.  Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells. , 1996, The Journal of infectious diseases.

[287]  C. Lingwood,et al.  Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes , 1996, Glycoconjugate Journal.

[288]  V. L. Tesh,et al.  Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines , 1996, Infection and immunity.

[289]  C. Lingwood.  Role of verotoxin receptors in pathogenesis. , 1996, Trends in microbiology.

[290]  J. Müthing.  High-resolution thin-layer chromatography of gangliosides. , 1996, Journal of chromatography. A.

[291]  G. Remuzzi,et al.  Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. , 1995, Blood.

[292]  T. Obrig,et al.  Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. , 1995, The Journal of infectious diseases.

[293]  C. Lingwood,et al.  Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin , 1995, Infection and immunity.

[294]  K. Sandvig,et al.  Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants. , 1995, Experimental cell research.

[295]  T. Kooistra,et al.  Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C. , 1995, Blood.

[296]  H. Augustin,et al.  Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[297]  R. Siegler.  Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. , 1994, The Journal of pediatrics.

[298]  T. Obrig,et al.  Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro. , 1994, Microvascular research.

[299]  C. Lingwood,et al.  Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro , 1993, Infection and immunity.

[300]  C. Lingwood,et al.  Endothelial heterogeneity in Shiga toxin receptors and responses. , 1993, The Journal of biological chemistry.

[301]  D. Marcus,et al.  Variable subcellular localization of glycosphingolipids. , 1993, Glycobiology.

[302]  V. V. van Hinsbergh,et al.  Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. , 1992, Blood.

[303]  Kristian Prydz,et al.  Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum , 1992, Nature.

[304]  T. Obrig,et al.  Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro , 1992, Infection and immunity.

[305]  C. Lingwood,et al.  Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. , 1992, Biochemistry.

[306]  Deborah A. Brown,et al.  Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface , 1992, Cell.

[307]  S. Goerdt,et al.  Endothelial heterogeneity and the acquired immunodeficiency syndrome: a paradigm for the pathogenesis of vascular disorders , 1992, The clinical investigator.

[308]  C. Lingwood,et al.  cells to Shiga toxin . sensitivity of human umbilical vein endothelial syndrome : effect of sodium butyrate on Shiga toxin-associated hemolytic uremic , 1991 .

[309]  C. Lingwood,et al.  Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. , 1991, The Journal of biological chemistry.

[310]  J. Heath,et al.  Association of glycosphingolipids with intermediate filaments of human umbilical vein endothelial cells. , 1991, Experimental cell research.

[311]  D. Lewis,et al.  Interferon-γ alters expression of endothelial cell-surface glycosphingolipids , 1990 .

[312]  S. Ostroff,et al.  Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. , 1989, The Journal of infectious diseases.

[313]  C. Lingwood,et al.  Globotetraosylceramide is recognized by the pig edema disease toxin. , 1989, The Journal of biological chemistry.

[314]  B. Domon,et al.  A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates , 1988, Glycoconjugate Journal.

[315]  L. Becker,et al.  The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. , 1988, Human pathology.

[316]  J. Brown,et al.  Direct cytotoxic action of Shiga toxin on human vascular endothelial cells , 1988, Infection and immunity.

[317]  C. Lingwood,et al.  Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. , 1988, Biochemical and biophysical research communications.

[318]  B. Domon,et al.  Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. , 1988, Biochemistry.

[319]  M. P. Jackson,et al.  Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933 , 1987 .

[320]  M. Jones,et al.  Glycosphingolipids of human umbilical vein endothelial cells and smooth muscle cells. , 1987, Archives of biochemistry and biophysics.

[321]  C. Lingwood,et al.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. , 1987, The Journal of biological chemistry.

[322]  C. Edgell,et al.  Permanent cell line expressing human factor VIII-related antigen established by hybridization. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[323]  L. Teel,et al.  Pathogenesis of Shiga-toxin producing escherichia coli. , 2012, Current topics in microbiology and immunology.

[324]  Silvia Scolari,et al.  Applications of fluorescence lifetime spectroscopy and imaging to lipid domains in vivo. , 2012, Methods in enzymology.

[325]  K. Sandvig,et al.  Shiga toxins. , 2012, Toxicon : official journal of the International Society on Toxinology.

[326]  Y. Takata,et al.  Encephalopathy, disseminated intravascular coagulation, and hemolytic–uremic syndrome after infection with enterohemorrhagic Escherichia coli O111 , 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[327]  J. Avorn.  Eculizumab in Severe Shiga-Toxin-Associated HUS , 2011 .

[328]  F. Obata,et al.  Influence of Escherichia coli shiga toxin on the mammalian central nervous system. , 2010, Advances in applied microbiology.

[329]  I. Nabi,et al.  Lipid rafts, caveolae, and their endocytosis. , 2010, International review of cell and molecular biology.

[330]  Y. Hannun,et al.  An overview of sphingolipid metabolism: from synthesis to breakdown. , 2010, Advances in experimental medicine and biology.

[331]  B. Binnington,et al.  New aspects of the regulation of glycosphingolipid receptor function. , 2010, Chemistry and physics of lipids.

[332]  D. Chi,et al.  Endothelial cell biology: role in the inflammatory response. , 2010, Advances in clinical chemistry.

[333]  J. Slotte,et al.  How the molecular features of glycosphingolipids affect domain formation in fluid membranes. , 2009, Biochimica et biophysica acta.

[334]  Patrik Langehanenberg,et al.  Automated three-dimensional tracking of living cells by digital holographic microscopy. , 2009, Journal of biomedical optics.

[335]  N. Loberto,et al.  Glycosphingolipid behaviour in complex membranes. , 2009, Biochimica et biophysica acta.

[336]  W. Aird.  Endothelium in health and disease. , 2008, Pharmacological reports : PR.

[337]  J. Thiem,et al.  Glycoscience : chemistry and chemical biology , 2008 .

[338]  S. Sonnino,et al.  Gangliosides as components of lipid membrane domains. , 2007, Glycobiology.

[339]  S. Sahni.  Endothelial cell infection and hemostasis. , 2007, Thrombosis research.

[340]  W. Lencer,et al.  Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER. , 2007, FEMS microbiology letters.

[341]  S. Levery.  Glycosphingolipid structural analysis and glycosphingolipidomics. , 2005, Methods in enzymology.

[342]  K. Jacobson,et al.  Detecting microdomains in intact cell membranes. , 2005, Annual review of physical chemistry.

[343]  W. Lencer.  Retrograde transport of cholera toxin into the ER of host cells. , 2004, International journal of medical microbiology : IJMM.

[344]  C. Lingwood,et al.  Methods for the identification of host receptors for Shiga toxin. , 2003, Methods in molecular medicine.

[345]  R. Benz,et al.  Detection and characterization of EHEC-hemolysin. , 2003, Methods in molecular medicine.

[346]  D. Kohan,et al.  Induction of apoptosis of human brain microvascular endothelial cells by shiga toxin 1. , 2003, The Journal of infectious diseases.

[347]  Akihiro Kusumi,et al.  Relationship of lipid rafts to transient confinement zones detected by single particle tracking. , 2002, Biophysical journal.

[348]  A. Friedrich,et al.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.

[349]  J. Rutka,et al.  The treatment of malignant meningioma with verotoxin. , 2002, Neoplasia.

[350]  S. Hakomori.  Inaugural Article : The glycosynapse , 2002 .

[351]  E. Heinz,et al.  Chemical Biology and Biomedicine: Glycolipids and Glycosphingolipids , 2001 .

[352]  R. Kannagi.  Monoclonal anti-glycosphingolipid antibodies. , 2000, Methods in enzymology.

[353]  J. Müthing,et al.  Analyses of glycosphingolipids by high-performance liquid chromatography. , 2000, Methods in enzymology.

[354]  C. Lingwood,et al.  Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice. , 1999, Oncology research.

[355]  J. Müthing.  TLC in structure and recognition studies of glycosphingolipids. , 1998, Methods in molecular biology.

[356]  R. G. Anderson.  The caveolae membrane system. , 1998, Annual review of biochemistry.

[357]  C. Lingwood.  Verotoxin-binding in human renal sections. , 1994, Nephron.

[358]  M. P. Jackson,et al.  Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. , 1992, Current topics in microbiology and immunology.

[359]  A. Leung,et al.  Causes of death in hemolytic uremic syndrome. , 1991, Child nephrology and urology.

[360]  K. Karlsson.  Animal glycosphingolipids as membrane attachment sites for bacteria. , 1989, Annual review of biochemistry.

[361]  C. Sweeley,et al.  Glycosphingolipids: structure, biological source, and properties. , 1989, Methods in enzymology.

[362]  T. Yutsudo,et al.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. , 1988, European journal of biochemistry.

[363]  Joshua Jortner,et al.  Nomenclature of retinoids: recommendations 1981. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). , 1983, Archives of biochemistry and biophysics.